Live Status Check

NCT02323399 Recruiting Status

Real-time enrollment status for this based on the clinical trial data provided, this appears to be a pharmacokinetic study of phenylephrine's effects on blood pressure rather than a study targeting a specific patient-facing medical condition. the study is investigating the drug's mechanism of action on blood pressure via iv administration. however, since phenylephrine is commonly used to treat hypotension (low blood pressure), the most likely primary condition patients would search for is: low blood pressure clinical trial

Current Status

Recruiting

Auto-verified from ClinicalTrials.gov

Checked: March 2, 2026 at 11:51 AM UTC

NCT02323399 Status Summary

NCT NumberNCT02323399
Recruiting StatusRecruiting
ConditionBased on the clinical trial data provided, this appears to be a pharmacokinetic study of phenylephrine's effects on blood pressure rather than a study targeting a specific patient-facing medical condition. The study is investigating the drug's mechanism of action on blood pressure via IV administration. However, since phenylephrine is commonly used to treat hypotension (low blood pressure), the most likely primary condition patients would search for is: Low Blood Pressure
PhaseClinical Trial
Target Enrollment100 participants
Active Locations10 sites in the US
SponsorWest-Ward Pharmaceutical
Last Updated on CT.govJuly 23, 2024 (Jul 23, 2024)

About NCT02323399 Enrollment Status

As of March 2, 2026: Clinical trial NCT02323399 is currently recruiting participants. This clinical trial study for based on the clinical trial data provided, this appears to be a pharmacokinetic study of phenylephrine's effects on blood pressure rather than a study targeting a specific patient-facing medical condition. the study is investigating the drug's mechanism of action on blood pressure via iv administration. however, since phenylephrine is commonly used to treat hypotension (low blood pressure), the most likely primary condition patients would search for is: low blood pressure is actively seeking new participants at 10 locations across the United States. The study is sponsored by West-Ward Pharmaceutical. This status information is automatically verified from the official ClinicalTrials.gov registry.

Frequently Asked Questions About NCT02323399

Is NCT02323399 still recruiting?

Yes, NCT02323399 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.

Where is NCT02323399 recruiting?

This trial is recruiting at 10 locations in the United States. View all available locations on the full study page.

How do I enroll in NCT02323399?

Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.

When was NCT02323399 status last updated?

The official ClinicalTrials.gov record for NCT02323399 was last updated Jul 23, 2024 (July 23, 2024). HelloStudys verifies this status automatically.

Browse More Based on the clinical trial data provided, this appears to be a pharmacokinetic study of phenylephrine's effects on blood pressure rather than a study targeting a specific patient-facing medical condition. The study is investigating the drug's mechanism of action on blood pressure via IV administration. However, since phenylephrine is commonly used to treat hypotension (low blood pressure), the most likely primary condition patients would search for is: Low Blood Pressure Trials

Ready to Apply?

Check your eligibility for this clinical trial